Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio
For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as "bad cholesterol") low enough on statins alone, the strongest backup has meant needles. That changed on July 16,
Merck created a new pill that helps people lower bad cholesterol when regular medicine doesn't work well enough. This is exciting news for the company because many people might want this easier option instead of needles.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.